CIDEC (Cell Death-Inducing DFFA-like Effector C), also known as FSP27 (Fat-Specific Protein 27), is a lipid droplet-associated protein critical in regulating lipid metabolism, adipocyte differentiation, and energy homeostasis. It plays a key role in promoting lipid droplet fusion and lipid storage, particularly in white adipose tissue. Dysregulation of CIDEC has been linked to metabolic disorders, including insulin resistance, obesity, and lipodystrophy, making it a research focus in studying obesity-related pathologies and metabolic syndrome.
CIDEC antibodies are essential tools for detecting and quantifying CIDEC protein expression in experimental models. They enable researchers to investigate CIDEC's spatial and temporal expression patterns, its interaction with lipid droplets, and its regulatory mechanisms in cellular and tissue contexts. These antibodies are widely used in techniques such as Western blotting, immunofluorescence, immunohistochemistry, and flow cytometry. Validation of CIDEC antibodies is crucial due to potential cross-reactivity with homologous proteins (e.g., CIDEA/B) and tissue-specific expression variations. High-quality antibodies help elucidate CIDEC's role in lipid dynamics, thermogenesis, and its crosstalk with signaling pathways like PPARγ, providing insights into therapeutic strategies for metabolic diseases.